BioSpace News Archive

Biotech Bay

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

NovaBay ® Pharmaceuticals, Inc. , announces that the Company has entered into an agreement to sell its DERMAdoctor ® skincare business including all product inventory for approximately $1.0 million in cash.

March 14, 2024
·
6 min read
Drug Development

OcuTerra Announces Topline Data from Phase 2 DR:EAM Trial Evaluating Nesvategrast (OTT166 5%) for Patients with Diabetic Retinopathy

OcuTerra Therapeutics, Inc. today announced topline results from its Phase 2 DR:EAM (Diabetic Retinopathy: Early Active Management) clinical trial of nesvategrast (OTT166), a novel, selective RGD integrin inhibitor developed as an eye drop.

March 14, 2024
·
5 min read
Business

IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*

IPA (IMMUNOPRECISE ANTIBODIES LTD.) today reported financial results for its third quarter of the 2024 fiscal year (“FY24”), which ended January 31, 2024.

March 14, 2024
·
8 min read
Bio NC

Inhalon Biopharma Announces Two Publications Advancing its Inhaled Antibody Treatment Platform for Acute Respiratory Infections

Inhalon Biopharma today announced the publication of preclinical data showcasing the advantages and efficacy of its “muco-trapping” technology in animal models of respiratory syncytial virus (RSV) and SARS-CoV-2 infections.

March 14, 2024
·
4 min read
Business

UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102

UroGen Pharma Delivers Double Digit JELMYTO ® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102.

March 14, 2024
·
20 min read
Business

Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2023 Financial Results and Business Highlights Conference Call

Arcadia Biosciences, Inc. today announced that it will release its financial and business results for the fourth quarter and full year of 2023 after market close on March 28, 2024.

March 14, 2024
·
1 min read
Pharm Country

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians

Milestone Scientific Inc. today announced that it has commenced sales of CompuFlo ® Epidural disposables to Omaha Pain Physicians , a comprehensive medical pain management center in Omaha, NE.

March 14, 2024
·
3 min read
Biotech Bay

First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG

HeartBeam, Inc. announced today that it has enrolled the first patients in the VALID-ECG ( Clinical Validation of the AIMIGo 12-Lead ECG Synthesis Software for Arrhythmia Detection ) pivotal study.

March 14, 2024
·
5 min read
Business

QT Imaging’s Breast Acoustic CT™ Scanner Used in Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

QT Imaging Holdings, Inc. is pleased to announce the delivery of a Breast Acoustic CT™ Scanner under a unique collaboration with the Department of Radiation Oncology, and Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toronto, Canada.

March 14, 2024
·
4 min read
Genetown

NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy

NeuroMetrix, Inc. noted the recent publication of a large study demonstrating that DPNCheck® combined with standard EKG or DPNCheck alone accurately detects diabetic peripheral neuropathy.

March 14, 2024
·
2 min read